Jane Street
TNGX icon

Jane Street’s Tango Therapeutics TNGX Stock Holding History

Jane Street’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Buy
+24,000
New +$593K ﹤0.01% 7151

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jane Street's TNGX Position: Q2 2026 in Review

Jane Street opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 514,265 shares worth $16.1M. The stake represents ﹤0.01% of the portfolio and ranks #2352 among its holdings. This is a return to the name: Jane Street previously reported a position in TNGX as recently as Q1 2025.

Jane Street first reported a position in TNGX in Q1 2022 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Jane Street held 514,265 shares of Tango Therapeutics worth $16.1M as of Q2 2026.
  • Tango Therapeutics was a new Jane Street position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2352 holding.
  • Jane Street first reported a position in Tango Therapeutics in Q1 2022 and has held it in 10 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.